Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: LANSOPRAZOLE — Supplemental Application (Xiromed LLC)

View source ↗

Summary

FDA approved a supplemental application for lansoprazole by Xiromed LLC, indicating an approved update to an already-approved product (such as labeling or indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)

Snippet

SUPPL AP for LANSOPRAZOLE (LANSOPRAZOLE)